A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease

被引:0
|
作者
Jinli Zhang
Xiaohui Zheng
Zhenying Zhao
机构
[1] Tianjin Second People’s Hospital,Department of Pharmacy
[2] Tianjin Union Medical Center,Department of Pharmacy
来源
BMC Neurology | / 23卷
关键词
Alzheimer’s disease; SSRI; Depression; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    Zhou, C.
    Fang, L.
    Chen, Y.
    Zhong, J.
    Wang, H.
    Xie, P.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (06) : 1243 - 1251
  • [32] Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
    C. Zhou
    L. Fang
    Y. Chen
    J. Zhong
    H. Wang
    P. Xie
    Osteoporosis International, 2018, 29 : 1243 - 1251
  • [33] The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis
    Jensen, Melanie P.
    Ziff, Oliver J.
    Banerjee, Gargi
    Ambler, Gareth
    Werring, David J.
    EUROPEAN STROKE JOURNAL, 2019, 4 (02) : 144 - 152
  • [34] Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis
    Masarwa, Reem
    Bar-Oz, Benjamin
    Gorelik, Einat
    Reif, Shimon
    Perlman, Amichai
    Matok, Ilan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : 57 - +
  • [35] Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis
    Gao, Yaqi
    Liu, Yulin
    Li, Yanfang
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 33 (11): : 1179 - 1187
  • [36] Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents A Systematic Review and Meta-analysis
    Locher, Cosima
    Koechlin, Helen
    Zion, Sean R.
    Werner, Christoph
    Pine, Daniel S.
    Kirsch, Irving
    Kessler, Ronald C.
    Kossowsky, Joe
    JAMA PSYCHIATRY, 2017, 74 (10) : 1011 - 1020
  • [37] Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis
    Foley, P.
    Lawler, A.
    Chandran, S.
    Mead, G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (06): : 709 - 710
  • [38] Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis
    Stefansdottir, Iris Harpa
    Ivarsson, Tord
    Skarphedinsson, Gudmundur
    NORDIC JOURNAL OF PSYCHIATRY, 2023, 77 (02) : 137 - 146
  • [39] Assessing the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for Managing COVID-19 Patients: A Systematic Review and Meta-Analysis
    Zhou, F.
    Deng, J.
    Rayner, D.
    Ramaraju, H.
    Abbas, U.
    Huang, E.
    Lohit, S.
    Heybati, K.
    Garcia, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [40] Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: A systematic review and meta-analysis
    Shah, N. R.
    Jones, J. B.
    Aperi, J.
    Shemlov, R.
    Karne, A.
    Borenstein, J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 58 - 58